Skip to main content
profile with neuro disease

Our Mission

Our goal is to develop collaborative, impactful research that will lead to improved brain health for the people of Cleveland, and for all.

NervGen develops first-in-class neuroreparative therapies.

NervGen celebrates successful Phase1b/2a trial

NervGen, founded by the late Jerry Silver, recently completed a clinical trial on their novel compound NVG-291 for the pharmacologic treatment of chronic spinal cord injury. The results showed lasting improvement in limb and bladder function and quality of life in patients treated with the novel compound.

Lightbulb with brain filament

The Latest

We hope to see you at the Breakthroughs in Cancer Neurosciences event on October 5th. Hear how we are combining the forces of two outstanding research programs, the Case Comprehensive Cancer Center and the Department of Neurosciences, to better understand the challenges of neuro-oncology from diagnosing and treating tumors of the brain and spinal cord to addressing nervous system issues caused by other types of cancer.